IP Library Granted Patent US 12,290,704
Granted Patent B2
US 12,290,704 · App. 18/312,684 · Granted May 6, 2025

Dose aspects of radiation therapy planning and treatment

Inventors: Reynald Vanderstraeten (Brussels, BE); Eric Abel (San Jose, CA); Christel Smith (Santa Barbara, CA); Anthony Magliari (Swansea, IL); Timo Koponen (Espoo, FI); Stanley Mansfield (Sunnyvale, CA); Charles Adelsheim (Mountain View, CA)
Assignee: SIEMENS HEALTHINEES INTERNATIONAL AG
A61N5/1031A61N5/1038A61N5/1045G16H10/60G16H20/40G16H40/63G16H50/50A61B6/032A61N5/1043A61N5/1069A61N5/1071
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,290,704
App. No.
18/312,684
Granted
May 6, 2025
Kind
B2
Abstract

Radiation treatment planning includes accessing values of parameters such as a number of beams to be directed into sub-volumes in a target, beam directions, and beam energies. Information that specifies limits for the radiation treatment plan are accessed. The limits include a limit on irradiation time for each sub-volume outside the target. Other limits can include a limit on irradiation time for each sub-volume in the target, a limit on dose rate for each sub volume in the target, and a limit on dose rate for each sub-volume outside the target. The values of the parameters are adjusted until the irradiation time for each sub-volume outside the target satisfies the maximum limit on irradiation time.

Claims (49)

1. A computer-implemented method of radiation treatment planning, the method comprising:

accessing values of parameters from memory of a computing system;

accessing information of a limit for a radiation treatment plan;

adjusting the values of the parameters until a dose rate for each sub-volume inside a target satisfies the limit; and

storing the values of the parameters after said adjusting in the memory of the computing system as a part of the radiation treatment plan.

2. The method of claim 1 , wherein the parameters comprise a number of beams to be directed into sub-volumes of the target and each portion of the beams that is in the target is represented as a respective set of longitudinal beam regions, and wherein the method further comprises:

for each of the beam regions, computing a dose rate to be delivered by a beam region and assigning a value to the beam region corresponding to the dose rate; and

for each of the sub-volumes in the target, computing a total value for the sub-volume by adding together the value for each beam region of each beam that reaches the sub-volume;

wherein said adjusting further comprises adjusting the parameters that affect the computed dose rates to be delivered by the beam regions until differences between respective total values for the sub-volumes in the target satisfy a threshold value.

3. The method of claim 1 , wherein said adjusting further comprises:

determining whether a beam overlaps any other beams outside a target; and

weighting beam intensities for beam segments of the beam according to how many other beams are overlapped by the beam outside the target.

4. The method of claim 1 , further comprising:

performing a dose calculation for an outside-the-target sub-volume, wherein said performing a dose calculation includes,

accessing a value for a dose calculation factor for the outside-the-target sub-volume, wherein the value for the dose calculation factor is determined according to how many beams reach the outside-the-target sub-volume;

calculating a dose for the outside-the-target sub-volume; and

applying the value of the dose calculation factor to the dose calculated for the outside-the-target sub-volume.

5. The method of claim 4 , wherein the dose calculation factor reduces the dose calculated for the outside-the-target sub-volume if only one beam reaches the outside-the-target sub-volume.

6. The method of claim 1 , wherein the limit includes at least one of

a maximum limit on irradiation time for each sub-volume outside the target; and

a minimum limit on a dose rate for each sub-volume outside the target.

7. The method of claim 1 , wherein the limit is based on a dose threshold, and wherein the dose threshold is dependent on a tissue type.

8. The method of claim 1 , wherein the parameters comprise a number of beams to be directed into sub-volumes of the target and the beams comprise a type of beam selected from the group consisting of: proton;

electron; photon; atom nuclei; and ion.

9. The method of claim 1 , wherein the parameters comprise a number of beams to be directed into sub-volumes of the target and the method further comprises:

adjusting the values of the parameters that affect calculated dose rates to be delivered by the beams until calculated total dose rates for the sub-volumes in the target are each within a specified range.

10. A computer-implemented method of radiation treatment planning, the method comprising:

accessing a value of a prescribed dose to be delivered into and across a target volume; and

determining beams of radiation to be directed into the target volume, wherein an amount of overlap between portions of the beams outside the target volume is less than a threshold value and wherein a predicted dose delivered by the beams satisfies the value of the prescribed dose.

11. The method of claim 10 , wherein the threshold value is zero.

12. The method of claim 10 , wherein the amount of overlap is a total amount of overlap of all of the portions of the beams outside the target volume.

13. The method of claim 10 , wherein the amount of overlap is a total amount of overlap of all of the portions of the beams outside the target volume, wherein at least some of the beams overlap within the target volume, and wherein the threshold value is a total amount of overlap of portions of the beams that overlap within the target volume.

14. The method of claim 10 , wherein the beams comprise a type of beam selected from the group consisting of: proton; electron; photon; atom nuclei; and ion.

15. The method of claim 10 , wherein regions outside the target volume comprise a plurality of sub-volumes, and wherein each sub-volume of the plurality of sub-volumes outside the target volume is not intersected by more than two of the beams.

16. A system for radiation treatment planning, the system comprising:

a memory storing values of parameters; and

at least one processing device, the at least one processing device configured to cause the system to,

access values of parameters from the memory,

access information of a limit for a radiation treatment plan, and

adjust the values of the parameters until a dose rate for each sub-volume inside a target satisfies the limit,

the memory being configured to store the values of the parameters after said adjusting the values as a part of the radiation treatment plan.

17. The system of claim 16 , wherein the limit includes at least one of

a maximum limit on irradiation time for each sub-volume outside the target; and

a minimum limit on a dose rate for each sub-volume outside the target.

18. The system of claim 16 , wherein the limit is based on a dose threshold, and wherein the dose threshold is dependent on a tissue type.

19. The system of claim 16 , wherein the parameters comprise a number of beams to be directed into sub-volumes of the target and the beams comprise a type of beam selected from the group consisting of: proton;

electron; photon; atom nuclei; and ion.

20. The system of claim 16 , wherein the parameters comprise a number of beams to be directed into sub-volumes of the target and the at least one processing device is configured to cause the system to,

adjust the values of the parameters that affect calculated dose rates to be delivered by the beams until calculated total dose rates for the sub-volumes in the target are each within a specified range.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2025
From: VARIAN MEDICAL SYSTEMS, INC.
To: SIEMENS HEALTHINEERS INTERNATIONAL AG
Reel/Frame 070481/0388 →
CHANGE OF NAME Recorded Mar 12, 2025
From: VARIAN MEDICAL SYSTEMS INTERNATIONAL AG
To: SIEMENS HEALTHINEERS INTERNATIONAL AG
Reel/Frame 070482/0520 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2025
From: VANDERSTRATEN, REYNALD; KOPONEN, TIMO
To: VARIAN MEDICAL SYSTEMS INTERNATIONAL AG
Reel/Frame 070005/0845 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2025
From: ABEL, ERIC; SMITH, CHRISTEL; MAGLIARI, ANTHONY; MANSFIELD, STANLEY; ADELSHEIM, CHARLES
To: VARIAN MEDICAL SYSTEMS, INC.
Reel/Frame 070005/0929 →
Continuity (4)
Continuation 17091445 · Nov 6, 2020
Continuation 16146972 · Sep 28, 2018
Continuation 15657094 · Jul 21, 2017
Related Publication 20230271030A1 · Aug 31, 2023
References Cited (317)
US 4163901A · Azam et al. · 1979 [cited by applicant]
US 4914681A · Klingenbeck et al. · 1990 [cited by applicant]
US 5153900A · Nomikos et al. · 1992 [cited by applicant]
US 5222544A · Dillon et al. · 1993 [cited by applicant]
US 5260005A · Ishigaki et al. · 1993 [cited by applicant]
US 5267294A · Kuroda et al. · 1993 [cited by applicant]
US 5379380A · Mori et al. · 1995 [cited by applicant]
US 5411675A · Usuki et al. · 1995 [cited by applicant]
US 5504899A · Raz · 1996 [cited by applicant]
US 5550378A · Skillicorn et al. · 1996 [cited by applicant]
US 5610967A · Moorman et al. · 1997 [cited by applicant]
US 5625663A · Swerdloff et al. · 1997 [cited by applicant]
US 5682412A · Skillicorn et al. · 1997 [cited by applicant]
US 5757885A · Yao et al. · 1998 [cited by applicant]
US 5993112A · Neal · 1999 [cited by applicant]
US 6198802B1 · Elliott et al. · 2001 [cited by applicant]
US 6222544B1 · Tarr et al. · 2001 [cited by applicant]
US 6234671B1 · Solomon et al. · 2001 [cited by applicant]
US 6260005B1 · Yang et al. · 2001 [cited by applicant]
US 6445766B1 · Whitham · 2002 [cited by applicant]
US 6504899B2 · Pugachev et al. · 2003 [cited by applicant]
US 6580940B2 · Gutman · 2003 [cited by applicant]
US 7268358B2 · Ma et al. · 2007 [cited by applicant]
US 7453983B2 · Schildkraut et al. · 2008 [cited by applicant]
US 7515681B2 · Ebstein · 2009 [cited by applicant]
US 7522706B2 · Lu et al. · 2009 [cited by applicant]
US 7560715B2 · Pedroni · 2009 [cited by applicant]
US 7590219B2 · Maurer, Jr. et al. · 2009 [cited by applicant]
US 7616735B2 · Maciunas et al. · 2009 [cited by applicant]
US 7623623B2 · Raanes et al. · 2009 [cited by applicant]
US 7778691B2 · Zhang et al. · 2010 [cited by applicant]
US 7807982B2 · Nishiuchi et al. · 2010 [cited by applicant]
US 7831289B2 · Riker et al. · 2010 [cited by applicant]
US 7835492B1 · Sahadevan · 2010 [cited by applicant]
US 7907699B2 · Long et al. · 2011 [cited by applicant]
US 8284898B2 · Ho et al. · 2012 [cited by applicant]
US 8306184B2 · Chang et al. · 2012 [cited by applicant]
US 8401148B2 · Lu et al. · 2013 [cited by applicant]
US 8406844B2 · Ruchala et al. · 2013 [cited by applicant]
US 8559596B2 · Thomson et al. · 2013 [cited by applicant]
US 8600003B2 · Zhou et al. · 2013 [cited by applicant]
US 8613694B2 · Walsh · 2013 [cited by applicant]
US 8636636B2 · Shukla et al. · 2014 [cited by applicant]
US 8644571B1 · Schulte et al. · 2014 [cited by applicant]
US 8716663B2 · Brusasco et al. · 2014 [cited by applicant]
US 8836332B2 · Shvartsman et al. · 2014 [cited by applicant]
US 8847179B2 · Fujitaka et al. · 2014 [cited by applicant]
US 8903471B2 · Heid · 2014 [cited by applicant]
US 8917813B2 · Maurer, Jr. · 2014 [cited by applicant]
US 8948341B2 · Beckman · 2015 [cited by applicant]
US 8958864B2 · Amies et al. · 2015 [cited by applicant]
US 8983573B2 · Carlone et al. · 2015 [cited by applicant]
US 8986186B2 · Zhang et al. · 2015 [cited by applicant]
US 8992404B2 · Graf et al. · 2015 [cited by applicant]
US 8995608B2 · Zhou et al. · 2015 [cited by applicant]
US 9018603B2 · Loo et al. · 2015 [cited by applicant]
US 9033859B2 · Fieres et al. · 2015 [cited by applicant]
US 9079027B2 · Agano et al. · 2015 [cited by applicant]
US 9149656B2 · Tanabe · 2015 [cited by applicant]
US 9155908B2 · Meltsner et al. · 2015 [cited by applicant]
US 9233260B2 · Slatkin et al. · 2016 [cited by applicant]
US 9258876B2 · Cheung et al. · 2016 [cited by applicant]
US 9283406B2 · Prieels · 2016 [cited by applicant]
US 9308391B2 · Liu et al. · 2016 [cited by applicant]
US 9330879B2 · Lewellen et al. · 2016 [cited by applicant]
US 9333374B2 · Iwata · 2016 [cited by applicant]
US 9468777B2 · Fallone et al. · 2016 [cited by applicant]
US 9517358B2 · Velthuis et al. · 2016 [cited by applicant]
US 9526918B2 · Kruip · 2016 [cited by applicant]
US 9545444B2 · Strober et al. · 2017 [cited by applicant]
US 9583302B2 · Figueroa Saavedra et al. · 2017 [cited by applicant]
US 9636381B2 · Basile · 2017 [cited by applicant]
US 9636525B1 · Sahadevan · 2017 [cited by applicant]
US 9649298B2 · Djonov et al. · 2017 [cited by applicant]
US 9656098B2 · Goer · 2017 [cited by applicant]
US 9694204B2 · Hårdemark · 2017 [cited by applicant]
US 9776017B2 · Flynn et al. · 2017 [cited by applicant]
US 9786054B2 · Taguchi et al. · 2017 [cited by applicant]
US 9786093B2 · Svensson · 2017 [cited by applicant]
US 9786465B2 · Li et al. · 2017 [cited by applicant]
US 9795806B2 · Matsuzaki et al. · 2017 [cited by applicant]
US 9801594B2 · Boyd et al. · 2017 [cited by applicant]
US 9844358B2 · Wiggers et al. · 2017 [cited by applicant]
US 9854662B2 · Mishin · 2017 [cited by applicant]
US 9884206B2 · Schulte et al. · 2018 [cited by applicant]
US 9931522B2 · Bharadwaj et al. · 2018 [cited by applicant]
US 9962562B2 · Fahrig et al. · 2018 [cited by applicant]
US 9974977B2 · Lachaine et al. · 2018 [cited by applicant]
US 9987502B1 · Gattiker et al. · 2018 [cited by applicant]
US 10007961B2 · Grudzinski et al. · 2018 [cited by applicant]
US 10022564B2 · Thieme et al. · 2018 [cited by applicant]
US 10071264B2 · Liger · 2018 [cited by applicant]
US 10080912B2 · Kwak et al. · 2018 [cited by applicant]
US 10092774B1 · Vanderstraten et al. · 2018 [cited by applicant]
US 10183179B1 · Smith et al. · 2019 [cited by applicant]
US 10188875B2 · Kwak et al. · 2019 [cited by applicant]
US 10206871B2 · Lin et al. · 2019 [cited by applicant]
US 10212800B2 · Agustsson et al. · 2019 [cited by applicant]
US 10232193B2 · Iseki · 2019 [cited by applicant]
US 10258810B2 · Zwart et al. · 2019 [cited by applicant]
US 10272264B2 · Ollila et al. · 2019 [cited by applicant]
US 10279196B2 · West et al. · 2019 [cited by applicant]
US 10293184B2 · Pishdad et al. · 2019 [cited by applicant]
US 10307614B2 · Schnarr · 2019 [cited by applicant]
US 10307615B2 · Ollila et al. · 2019 [cited by applicant]
US 10315047B2 · Glimelius et al. · 2019 [cited by applicant]
US 10413755B1 · Sahadevan · 2019 [cited by applicant]
US 10449389B2 · Ollila et al. · 2019 [cited by applicant]
US 10485988B2 · Kuusela et al. · 2019 [cited by applicant]
US 10525285B1 · Friedman · 2020 [cited by applicant]
US 10549117B2 · Vanderstraten et al. · 2020 [cited by applicant]
US 10603514B2 · Grittani et al. · 2020 [cited by applicant]
US 10609806B2 · Roecken et al. · 2020 [cited by applicant]
US 10636609B1 · Bertsche et al. · 2020 [cited by applicant]
US 10660588B2 · Boyd et al. · 2020 [cited by applicant]
US 10661100B2 · Shen · 2020 [cited by applicant]
US 10682528B2 · Ansorge et al. · 2020 [cited by applicant]
US 10702716B2 · Heese · 2020 [cited by applicant]
US 10758746B2 · Kwak et al. · 2020 [cited by applicant]
US 10850124B2 · Vanderstraeten et al. · 2020 [cited by applicant]
US 10870018B2 · Bartkoski et al. · 2020 [cited by applicant]
US 20050276377A1 · Carol · 2005 [cited by applicant]
US 20060274061A1 · Wang et al. · 2006 [cited by applicant]
US 20070034812A1 · Ma et al. · 2007 [cited by applicant]
US 20070287878A1 · Fantini et al. · 2007 [cited by applicant]
US 20080023644A1 · Pedroni · 2008 [cited by applicant]
US 20090063110A1 · Failla et al. · 2009 [cited by applicant]
US 20090287467A1 · Sparks et al. · 2009 [cited by applicant]
US 20100119032A1 · Yan et al. · 2010 [cited by applicant]
US 20100177870A1 · Nord et al. · 2010 [cited by applicant]
US 20100178245A1 · Arnsdorf et al. · 2010 [cited by applicant]
US 20100260317A1 · Chang et al. · 2010 [cited by applicant]
US 20110006224A1 · Maltz et al. · 2011 [cited by applicant]
US 20110091015A1 · Yu et al. · 2011 [cited by applicant]
US 20110135058A1 · Sgouros et al. · 2011 [cited by applicant]
US 20120076271A1 · Yan et al. · 2012 [cited by applicant]
US 20120157746A1 · Meltsner et al. · 2012 [cited by applicant]
US 20120171745A1 · Itoh · 2012 [cited by applicant]
US 20120197058A1 · Shukla et al. · 2012 [cited by applicant]
US 20130116929A1 · Carlton et al. · 2013 [cited by applicant]
US 20130150922A1 · Butson et al. · 2013 [cited by applicant]
US 20130177641A1 · Ghoroghchian · 2013 [cited by applicant]
US 20130231516A1 · Loo et al. · 2013 [cited by applicant]
US 20140177807A1 · Lewellen et al. · 2014 [cited by applicant]
US 20140185776A1 · Li et al. · 2014 [cited by applicant]
US 20140206926A1 · van der Laarse · 2014 [cited by applicant]
US 20140275706A1 · Dean et al. · 2014 [cited by applicant]
US 20140369476A1 · Harding · 2014 [cited by applicant]
US 20150011817A1 · Feng · 2015 [cited by applicant]
US 20150202464A1 · Brand et al. · 2015 [cited by applicant]
US 20150306423A1 · Bharat et al. · 2015 [cited by applicant]
US 20160279444A1 · Schlosser · 2016 [cited by applicant]
US 20160310764A1 · Bharadwaj et al. · 2016 [cited by applicant]
US 20170165502A1 · Claereboudt et al. · 2017 [cited by applicant]
US 20170189721A1 · Sumanaweera et al. · 2017 [cited by applicant]
US 20170203129A1 · Dessy · 2017 [cited by applicant]
US 20170281973A1 · Allen et al. · 2017 [cited by applicant]
US 20180021594A1 · Papp et al. · 2018 [cited by applicant]
US 20180043183A1 · Sheng et al. · 2018 [cited by applicant]
US 20180056090A1 · Jordan et al. · 2018 [cited by applicant]
US 20180099154A1 · Prieels · 2018 [cited by applicant]
US 20180099155A1 · Prieels et al. · 2018 [cited by applicant]
US 20180099159A1 · Forton et al. · 2018 [cited by applicant]
US 20180154183A1 · Sahadevan · 2018 [cited by applicant]
US 20180197303A1 · Jordan et al. · 2018 [cited by applicant]
US 20180207425A1 · Carlton et al. · 2018 [cited by applicant]
US 20180236268A1 · Zwart et al. · 2018 [cited by applicant]
US 20190022407A1 · Abel et al. · 2019 [cited by applicant]
US 20190022422A1 · Trail et al. · 2019 [cited by applicant]
US 20190054315A1 · Isola et al. · 2019 [cited by applicant]
US 20190070435A1 · Joe Anto et al. · 2019 [cited by applicant]
US 20190111280A1 · Eriksson · 2019 [cited by applicant]
US 20190168027A1 · Smith et al. · 2019 [cited by applicant]
US 20190255361A1 · Mansfield · 2019 [cited by applicant]
US 20190299027A1 · Fujii et al. · 2019 [cited by applicant]
US 20190299029A1 · Inoue · 2019 [cited by applicant]
US 20190351259A1 · Lee et al. · 2019 [cited by applicant]
US 20200001118A1 · Snider, III et al. · 2020 [cited by applicant]
US 20200022248A1 · Yi et al. · 2020 [cited by applicant]
US 20200030633A1 · Van Heteren et al. · 2020 [cited by applicant]
US 20200035438A1 · Star-Lack et al. · 2020 [cited by applicant]
US 20200069818A1 · Jaskula-Ranga et al. · 2020 [cited by applicant]
US 20200164224A1 · Vanderstraten et al. · 2020 [cited by applicant]
US 20200178890A1 · Otto · 2020 [cited by applicant]
US 20200197730A1 · Safavi-Naeini et al. · 2020 [cited by applicant]
US 20200254279A1 · Ohishi · 2020 [cited by applicant]
US 20200269068A1 · Abel et al. · 2020 [cited by applicant]
US 20200276456A1 · Swerdloff · 2020 [cited by applicant]
US 20200282234A1 · Folkerts et al. · 2020 [cited by applicant]
CN 1926552A · 2007 [cited by applicant]
CN 1953782A · 2007 [cited by applicant]
CN 101014383A · 2007 [cited by applicant]
CN 102049102A · 2011 [cited by applicant]
CN 102770180A · 2012 [cited by applicant]
CN 103038669A · 2013 [cited by applicant]
CN 104001270A · 2014 [cited by applicant]
CN 105592887A · 2016 [cited by applicant]
CN 106061555A · 2016 [cited by applicant]
CN 106687177A · 2017 [cited by applicant]
CN 106730407A · 2017 [cited by applicant]
CN 107362464A · 2017 [cited by applicant]
CN 107847757A · 2018 [cited by applicant]
CN 109966662A · 2019 [cited by applicant]
CN 111481840A · 2020 [cited by applicant]
CN 111481841A · 2020 [cited by applicant]
EA 010207 · 2008 [cited by applicant]
EP 0979656A2 · 2000 [cited by applicant]
EP 2251063A1 · 2010 [cited by applicant]
EP 2823501A1 · 2015 [cited by applicant]
EP 3043863A1 · 2016 [cited by applicant]
EP 3047410A1 · 2016 [cited by applicant]
EP 3338858A1 · 2018 [cited by applicant]
EP 3384961A1 · 2018 [cited by applicant]
EP 3421087A1 · 2019 [cited by applicant]
EP 3453427A1 · 2019 [cited by applicant]
EP 3586920A1 · 2020 [cited by applicant]
JP 2617283B2 · 1997 [cited by applicant]
JP 2004201995A · 2004 [cited by applicant]
JP 2019097969A · 2019 [cited by applicant]
WO WO2007017177A1 · 2007 [cited by applicant]
WO WO2010018476A2 · 2010 [cited by applicant]
WO 2011162021A1 · 2011 [cited by applicant]
WO WO2013081218A2 · 2013 [cited by applicant]
WO WO2013133936A1 · 2013 [cited by applicant]
WO WO2014139493A1 · 2014 [cited by applicant]
WO WO2015038832A1 · 2015 [cited by applicant]
WO WO2015102680A2 · 2015 [cited by applicant]
WO WO2016122957A1 · 2016 [cited by applicant]
WO WO2017156316A1 · 2017 [cited by applicant]
WO WO2017174643A1 · 2017 [cited by applicant]
WO WO2018137772A1 · 2018 [cited by applicant]
WO WO2018152302A1 · 2018 [cited by applicant]
WO WO2019097250A1 · 2019 [cited by applicant]
WO WO2019103983A1 · 2019 [cited by applicant]
WO WO2019164835A1 · 2019 [cited by applicant]
WO WO2019166702A1 · 2019 [cited by applicant]
WO WO2019185378A1 · 2019 [cited by applicant]
WO WO2019222436A2 · 2019 [cited by applicant]
WO WO2020018904A1 · 2020 [cited by applicant]
WO WO2020064832A1 · 2020 [cited by applicant]
WO WO2020107121A1 · 2020 [cited by applicant]
WO WO2020159360A1 · 2020 [cited by applicant]
Chen, B. et al., “Establishment and application of voxel-by-voxel based objective dose in optimizing radiotherapy planning,” Nuclear Techniques, vol. 31, No. 5, May 2008. [cited by applicant]
Aafke Christine Kraan, “Range verification methods in particle therapy: underlying physics and Monte Carlo modeling,” Frontiers in Oncology, Jul. 7, 2015, vol. 5, Article 150, 27 pages, doi: 10.3389/fonc.2015 00150. [cited by applicant]
Wayne D. Newhauser et al., “The physics of proton therapy,” Physics in Medicine & Biology, Mar. 24, 2015, 60 R155-R209, Institute of Physics and Engineering in Medicine, IOP Publishing, doi: 10.1088/0031-9155/60/8/R155. [cited by applicant]
S E McGowan et al., “Treatment planning optimisation in proton therapy,” Br J Radiol, 2013, 86, 20120288, The British Institute of Radiology, 12 pages, DOI: 10.1259 bjr.20120288. [cited by applicant]
Steven Van De Water et al., “Towards FLASH proton therapy: the impact of treatment planning and machine characteristics on achievable dose rates,” Acta Oncologica, Jun. 26, 2019, vol. 58, No. 10, p. 1462-1469, Taylor 1 … [cited by applicant]
J. Groen, “FLASH optimisation in clinical IMPT treatment planning,” MSC Thesis, Jul. 1, 2020, Erasmus University Medical Center, department of radiotherapy, Delft University of Technology, 72 pages. [cited by applicant]
Muhammad Ramish Ashraf et aL, “Dosimetry for FLASH Radiotherapy: A Review of Tools and the Role of Radioluminescence and Cherenkov Emission,” Frontiers in Oncology, Aug. 21, 2020, vol. 8, Article 328, 20 rages, doi: 10.… [cited by applicant]
Emil Schuler et aL, “Experimental Platform for Ultra-high Dose Rate FLASH Irradiation of Small Animals Using a Clinical Linear Accelerator,” International Journal of Radiation Oncology, Biology, Physics, vol. 97, No. 1,… [cited by applicant]
Elette Engels et aL, “Toward personalized synchrotron microbeam radiation therapy,” Scientific Reports, 10:8833, )Jun. 1, 2020, 13 pages, DOI: https://doi.org/10.1038/s41598-020-65729-z. [cited by applicant]
P-H Mackeprang et aL, “Assessing dose rate distributions in VMAT plans” (Accepted Version),; Xccepted Version: https://boris.unibe.ch/92814/8/dose_rate_project_revised_submit.pdf; Published Version: 2016, Physics in med… [cited by applicant]
Xiaoying Liang et aL, “Using Robust Optimization for Skin Flashing in Intensity Modulated Radiation Therapy for Breast Cancer Treatment: A Feasibility Study,” Practical Radiation Oncology, vol. 10, Issue 1, p. 59-69, Pu… [cited by applicant]
Alexei Trofimov et aL, “Optimization of Beam Parameters and Treatment Planning for Intensity Modulated Proton Therapy,” Technology in Cancer Research & Treatment, vol. 2, No. 5, Oct. 2003, p. 437-444, Adenine Dress. [cited by applicant]
Vladimir Anferov, “Scan pattern optimization for uniform proton beam scanning,” Medical Physics, vol. 36, Issue 8, Aug. 2009, pp. 3560-3567, First published: Jul. 2, 2009. [cited by applicant]
Ryosuke Kohno et aL, “Development of Continuous Line Scanning System Prototype for Proton Beam Therapy,” Intemational Journal of Particle Therapy, Jul. 11, 2017, vol. 3, Issue 4, p. 429-438, DOL 10.14338/IJPT-16-00017.1. [cited by applicant]
Wenbo Gu et aL, “Integrated Beam Orientation and Scanning-Spot Optimization in Intensity Modulated Proton Therapy for Brain and Unilateral Head and Neck Tumors,” Med Phys. Author manuscript; available in PMC Apr. 1, 201… [cited by applicant]
Paul Morel et aL, “Spot weight adaptation for moving target in spot scanning proton therapy,” Frontiers in Oncology, May 28, 2015, vol. 5, Article 119, 7 pages, doi: 10.3389/fonc.2015.00119. [cited by applicant]
Simeon Nill et aL, “Inverse planning of intensity modulated proton therapy,” Zeitschrift fur Medizinische Physik, Colume 14, Issue 1, 2004, pp. 35-40, https://doi.org/10.1078/0939-3889-00198. [cited by applicant]
A. Lomax, intensity modulation methods for proton radiotherapy, Physics in Medicine & Biology, Jan. 1999, vol. 14, Issue 1, 2004, pp. 35-40, https://doi.org/10.1078/0939-3889-00198. [cited by applicant]
M. Kramer et aL, “Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization,” Physics in Medicine & Biology, 2000, vol. 45, No. 11, pp. 3299-3317, doi: 10.1088/0031-9155/45/11/313. [cited by applicant]
Harald Paganetti, “Proton Beam Therapy,” Jan. 2017, Physics World Discovery, IOP Publishing Ltd, Bristol, JK, 34 pages, DOI: 10 1088/978-0-7503-1370-4. [cited by applicant]
Shinichi Shimizu et al, “A Proton Beam Therapy System Dedicated to Spot-Scanning Increases Accuracy with Moving Tumors by Real-Time Imaging and Gating and Reduces Equipment Size,” PLoS ONE, Apr. 18, 2014, vol. 3, Issue … [cited by applicant]
Heng Li et al., “Reducing Dose Uncertainty for Spot-Scanning Proton Beam Therapy of Moving Tumors by Optimizing he Spot Delivery Sequence,” International Journal of Radiation Oncology, Biology, Physics, vol. 93, Issue 3… [cited by applicant]
On Beam Applications SA, “Netherlands Proton Therapy Center Delivers First Clinical Flash Irradiation,” Imaging Technology News, May 2, 2019, Wainscot Media, ittps://www.itnonline.com/content/netherlands-proton-therapy-… [cited by applicant]
R. M. De Kruijff, “FLASH radiotherapy: ultra-high dose rates to spare healthy tissue,” International Journal of Radiation Biology, 2020, vol. 96, No. 4, pp. 419-423, published online: Dec. 19, 2019, ittps://doi .org/10.… [cited by applicant]
Vievion Medical Systems, “Focus On The Future: Flash Therapy,” Press Releases, Sep. 16, 2019, ittps://www.mevion.com/newsroom/press-releases/focus-future-flash-therapy. [cited by applicant]
Joseph D. Wilson et al, “Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?”, Frontiers in Oncology, Jan. 17, 2020, vol. 9, Article 1563, 12 pages, doi: 10.3389/fonc 2019.01563. [cited by applicant]
David P. Gierga, “Is Flash Radiotherapy coming?”, International Organization for Medical Physics, 2020, ittps://www.iomp.org/iomp-news2-flash-radiotherapy/. [cited by applicant]
Abdullah Muhammad Zakaria et aL, “Ultra-High Dose-Rate, Pulsed (FLASH) Radiotherapy with Carbon Ions: Generation of Early, Transient, Highly Oxygenated Conditions in the Tumor Environment,” Radiation Research, Dec. 1, 2… [cited by applicant]
Yusuke Demizu et al, “Carbon Ion Therapy for Early-Stage Non-Small-Cell Lung Cancer,” BioMed Research International, vol. 2014, Article ID 727962, 9 pages, Hindawi Publishing Corporation, published: Sep. 11, 2014, ittps… [cited by applicant]
Ivana Dokic et aL, “Next generation multi-scale biophysical characterization of high precision cancer particle adiotherapy using clinical proton, helium-, carbon-and oxygen ion beams,” Oncotarget, Aug. 30, 2016, vol. 7,… [cited by applicant]
Aetna Inc., “Proton Beam, Neutron Beam, and Carbon Ion Radiotherapy,” 2020, No. 0270, ittp://www.aetna.com/cpb/medical/data/200_299/0270.html. [cited by applicant]
Nicholas W. Colangelo et al, “The Importance and Clinical Implications of FLASH Ultra-High Dose-Rate Studies or Proton and Heavy Ion Radiotherapy,” Radiat Res. Author manuscript; available in PMC Jan. 1, 2021.; ittps://… [cited by applicant]
Vincent Favaudon et al, “Ultrahigh dose-rate FLASH irradiation increases the differential response between lormal and tumor tissue in mice,” Science Translational Medicine, Jul. 16, 2014, vol. 6, Issue 245, 245ra93, Ame… [cited by applicant]
“FlashRad: Ultra-high dose-rate FLASH radiotherapy to minimize the complications of radiotherapy,” 2014, https://siric.curie.fr/sites/default/files/atoms/files/flashrad.pdf. [cited by applicant]
Tami Freeman, “FLASH radiotherapy: from preclinical promise to the first human treatment,” Physics World, Aug. 6, 2019, IOP Publishing Ltd, ittps://physicsworld.com/a/flash-radiotherapy-from-preclinical-promise-to-the-f… [cited by applicant]
Intraop Medical, Inc., “IntraOp and Lausanne University Hospital Announce Collaboration in FLASH adiotherapy,” Jun. 18, 2020, ittps://intraop.com/news-events/lausanne-university-flash-radiotherapy-collaboration/. [cited by applicant]
M.-C. Vozenin et al, “Biological Benefits of Ultra-high Dose Rate FLASH Radiotherapy: Sleeping Beauty Awoken,” Dlin Oncol (R Coll Radiol). Author manuscript; available in PMC Nov. 12, 2019.; ittps://www.ncbi.nlm.nih.gov… [cited by applicant]
Efstathios Kamperis et al, “A FLASH back to radiotherapy's past and then fast forward to the future,” J Cancer; Drev Curr Res. 2019;10(6):142-144. published Nov. 13, 2019,; DOI: 10.15406/jcpcr.2019.10.00407;. [cited by applicant]
P. Symonds et al, “FLASH Radiotherapy: The Next Technological Advance in Radiation Therapy?”, Clinical Oncology, vol. 31, Issue 7, p. 405-406, Jul. 1, 2019, The Royal College of Radiologists, Published by Elsevier Ltd.,… [cited by applicant]
Swati Girdhani et al, “Abstract LB-280: FLASH: A novel paradigm changing tumor irradiation platform that enhances therapeutic ratio by reducing normal tissue toxicity and activating immune pathways,” Proceedings: AACR X… [cited by applicant]
Bazalova-Carter et al, “On the capabilities of conventional x-ray tubes to deliver ultra-high (FLASH) dose rates,” Vied. Phys. Dec. 2019; 46 (12):5690-5695, published Oct. 23, 2019, American Association of Physicists in… [cited by applicant]
Manuela Buonanno et al, “Biological effects in normal cells exposed to FLASH dose rate protons,” Radiother Oncol. Author manuscript; available in PMC Oct. 1, 2020.; ittps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728238/;… [cited by applicant]
N. Rama et al, “Improved Tumor Control Through T-cell Infiltration Modulated by Ultra-High Dose Rate Proton FLASH Using a Clinical Pencil Beam Scanning Proton System,” International Journal of Radiation Oncology, Biolog… [cited by applicant]
Inserm Press Office, “Radiotherapy ‘flashes’ to reduce side effects,” Press Release, Jul. 16, 2014, ittps://presse.inserm.fr/en/radiotherapy-flashes-to-reduce-side-effects/13394/. [cited by applicant]
Eric S. Diffenderfer et al, “Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System,” International Journal of Radiation Oncology, Biology, Physics, vol. 106, Issue 2, Feb. 1, 20… [cited by applicant]
Valerie Devillaine, “Radiotherapy and Radiation Biology,” Institut Curie, Apr. 21, 2017, ittps7/institut-curieorg/page/radiotherapy-and-radiation-biology. [cited by applicant]
Imaging Technology News, “ProNova and medPhoton to Offer Next Generation Beam Delivery, Advanced maging for Proton Therapy,” Oct. 6, 2014, Wainscot Media,; _ink: https://www.itnonline.com/content/pronova-and-medphoton-o… [cited by applicant]
Oncolink Team, “Radiation Therapy: Which type is right for me?”, OncoLink Penn Medicine, last reviewed Mar. 3, 2020, Trustees of the University of Pennsylvania, ittps://wwwoncolinkorg/cancer-treatment/radiation/introduc… [cited by applicant]
Marco Durante et al, “Faster and safer? FLASH ultra-high dose rate in radiotherapy,” Br J Radiol 2018; 91(1082):; Jun. 28, 2017, British Institute of Radiology, Published Online: Dec. 15, 2017,; ittps://doi.org/10.1259/… [cited by applicant]
John R. Fischer, “PMB launches FLASH radiotherapy system for use in clinical trials,” Healthcare Business News,; Jun. 29, 2020, DOTmed.com, Inc.,; ittps://www.dotmed .com/news/story/51662;. [cited by applicant]
Marie-Catherine Vozenin et al., “The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients,” Clinical Cancer Research, Author Manuscript Published OnlineFirst Jun. 6, 2018, ittps://clincancerres.… [cited by applicant]
M. McManus et al, “The challenge of ionisation chamber dosimetry in ultra-short pulsed high dose-rate Very High Energy Electron beams,” Sci Rep 10, 9089 (2020), published Jun. 3, 2020, ittps://doi .org/10.1038/s41598-02… [cited by applicant]
Brahim Oraiqat et al, “An Ionizing Radiation Acoustic Imaging (iRAI) Technique for Real-Time Dosimetric Measurements for FLASH Radiotherapy,” Medical Physics, vol. 47, IssueIO, Oct. 2020, pp. 5090-5101, First published:… [cited by applicant]
K. Petersson et al, “Dosimetry of ultra high dose rate irradiation for studies on the biological effect induced in lormal brain and GBM,” ICTR-PHE 2016, p. S84, Feb. 2016, ittps://publisher-connector.core.ac.uk/resource… [cited by applicant]
Susanne Auer et al., “Survival of tumor cells after proton irradiation with ultra-high dose rates,” Radiation Oncology 2011, 6:139, Published Oct. 18, 2011, DOL https://doi.Org/10.1186/1748-717X-6-139. [cited by applicant]
Cynthia E. Keen, “Clinical linear accelerator delivers FLASH radiotherapy,” Physics World, Apr. 23, 2019, IOP; Publishing Ltd,; ittps://physicsworld.com/a/clinical-linear-accelerator-delivers-flash-radiotherapy/;. [cited by applicant]
Fan et al, “Emission guided radiation therapy for lung and prostate cancers: A feasibility study on a digital patient,” Med Phys. Nov. 2012; 39(11): 7140-7152. Published online Nov. 5, 2012.; ittps://www.ncbi.nlm.nih.go… [cited by applicant]
Favaudon et aL, “Ultrahigh dose-rate, “flash” irradiation minimizes the side-effects of radiotherapy,” Cancer/Radiotherapy, vol. 19, issues 6-7 , Oct. 2015, pp. 525-531, Available online Aug. 12, 2015, https://doi .org/… [cited by applicant]
O. Zlobinskaya et al, “The Effects of Ultra-High Dose Rate Proton Irradiation on Growth Delay in the Treatment of Human Tumor Xenografts in Nude Mice,” Radiation Research, 181(2):177-183. Published Feb. 13, 2014, DOL ht… [cited by applicant]
Bjorn Zackrisson, “Biological Effects Of High Energy Radiation And Ultra High Dose Rates,” Umea Jniversity Medical Dissertations, New series No. 315—ISSN 0346-6612, From the Department of Oncology, University of Umea, U… [cited by applicant]
P. Montay-Gruel et al, “Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with lose rates above 100 Gy/s,” Radiotherapy and Oncology, vol. 124, Issue 3, Sep. 2017, pp. 365-369, Avail… [cited by applicant]
BW Loo et al., “Delivery of Ultra-Rapid Flash Radiation Therapy and Demonstration of Normal Tissue Sparing After Abdominal Irradiation of Mice,” International Journal of Radiation Oncology, Biology, Physics, vol. 98, Is… [cited by applicant]
Bhanu Prasad Venkatesulu et al, “Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome,” Sci Rep 9, 17180 (2019), Publishe… [cited by applicant]
P. Montay-Gruel et al, “Long-term neurocognitive benefits of FLASH radiotherapy driven by reduced reactive oxygen species,” PNAS May 28, 2019, vol. 116, No. 22, pp. 10943-10951; first published May 16, 2019, https: //do… [cited by applicant]
Peter G. Maxim et al, “FLASH radiotherapy: Newsflash or flash in the pan?”, Medical Physics, 46 (10), Oct. 2019, pp. 4287-4290, American Association of Physicists in Medicine, First published: Jun. 27, 2019, ittps://doi… [cited by applicant]
Andrei Pugachev et IL, “Pseudo beam's-eye-view as applied to beam orientation selection in intensity-modulated radiation therapy,” Int. J. Radiation Oncology BioL Phys., vol. 51, Issue 5, p. 1361-1370, Dec. 1, 2001, DOL… [cited by applicant]
Xiaodong Zhang et al, “Intensity-Modulated Proton Therapy Reduces the Dose to Normal Tissue Compared With Intensity-Modulated Radiation Therapy or Passive Scattering Proton Therapy and Enables Individualized Radical Rad… [cited by applicant]
A. J. Lomax et al, “Intensity modulated proton therapy: A clinical example,” Medical Physics, vol. 28, Issue 3, Mar. 2001, pp. 17-324, First Published: Mar. 9, 2001, https:doi.org/10.11181/1.1350587. [cited by applicant]
Lamberto Widesott et al, “Intensity-Modulated Proton Therapy Versus Helical Tomotherapy in Nasopharynx Dancer: Planning Comparison and NTCP Evaluation,” Int. J. Radiation Oncology BioL Phys., vol. 72, No. 2, pp. 589-596… [cited by applicant]
Andrei Pugachev et al, “Role of beam orientation optimization in intensity-modulated radiation therapy,” Int. J. Radiation Oncology BioL Phys., vol. 50, No. 2, pp. 551-560, Jun. 1, 2001, Available online May 10, 2001, D… [cited by applicant]
Damien C. Weber et al, “Radiation therapy planning with photons and protons for eariy and advanced breast cancer: an overview,” Radiat Oncol. 2006; 1: 22. Published online Jul. 20, 2006, loi: 10.1186/1748-717X-1-22. [cited by applicant]
RaySearch Laboratories, “Leading the way in cancer treatment, Annual Report 2013,” RaySearch Laboratories (publ), Stockholm, Sweden, 94 pages, Apr. 2014,; ittps://www.raysearchlabs com/siteassets/about-overview/media-ce… [cited by applicant]
Fredrik Carlsson, “Utilizing Problem Structure in Optimization of Radiation Therapy,” KTH Engineering Sciences, Doctoral Thesis, Stockholm, Sweden, Apr. 2008, Optimization and Systems Theory, Department of Mathematics, … [cited by applicant]
Chang-Ming Charlie Ma, “Physics and Dosimetric Principles of SRS and SBRT,” Mathews J Cancer Sci. 4(2): 22, 2019, published: Dec. 11, 2019, ISSN: 2474-6797,; DOI: https://doi.org/10.30654/MJCS.10022;. [cited by applicant]
Alterego-admin, “Conventional Radiation Therapy May Not Protect Healthy Brain Cells,” Intemational Neuropsychiatric Association—INA, Oct. 10, 2019, ittps://inawebsite.org/conventional-radiation-therapy-may-not-protect-h… [cited by applicant]